K-numberK242842
Device nameANNE View, Central Hub
ApplicantSibel Health, Inc.
Product codeMSX
Device classClass II
Decision dateJan 8, 2025
DecisionSubstantially Equivalent
Regulation870.2300
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The ANNE View, Central Hub is a bedside patient monitoring system that displays physiological data (ECG, heart rate, respiratory rate, SpO2, blood pressure, temperature, and body position) from compatible sensors and third-party devices. It operates on a tablet and can transmit data wirelessly to a central monitoring hub for viewing and storing vital signs from up to 16 patients simultaneously, with alarming capabilities when data fall outside configured thresholds.

Technological characteristics

The device uses Android 14.0 operating system on the ANNE View tablet and Windows 11 for the Central Hub desktop application. Communication occurs via Bluetooth between the tablet and sensors, and LAN/WLAN between the tablet and Central Hub. It provides real-time monitoring with data storage capability up to 48 hours per patient and includes both visual and auditory alarms.

Test standards cited

Electromagnetic compatibility (IEC 60601-1-2:2020), wireless coexistence (ANSI IEEE C63.27-2017), software verification and validation (IEC 62304:2015), ECG waveform display verification (IEC 60601-2-27:2011 and IEC 60601-2-47:2012), usability testing (IEC 62366-1:2020), cybersecurity evaluation per FDA guidance, alarm system verification (IEC 60601-1-8:2020), and performance evaluation of HL7 FHIR and IEEE 11073 SDC communication protocols.

Substantial equivalence argument

The device demonstrates substantial equivalence through functional and technological parity with predicates: it displays real-time physiological data for patient monitoring in non-critical care settings like the predicates, employs comparable communication methods (Bluetooth and network-based transmission), provides equivalent alarm functionality, and serves the same intended user population (trained healthcare professionals). The performance testing across recognized consensus standards confirms safety and effectiveness equivalent to the predicate devices despite minor differences in operating system versions and the addition of interoperability with third-party FDA-cleared devices.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →